Synergistic activation by p38MAPK and glucocorticoid signaling mediates induction of M2-like tumor-associated macrophages expressing the novel CD20 homolog MS4A8A

International Journal of Cancer

Volumn 129, Issue 1, 2011, Pages 122-132

  Schmieder, Astrid ^a   Schledzewski, Kai ^a   Michel, Julia ^a   Tuckermann, Jan P ^b   Tome, Lydia ^a   Sticht, Carsten ^a   Gkaniatsou, Cleopatra ^a   Nicolay, Jan P ^a   Demory, Alexandra ^a   Faulhaber, Jörg ^a   Kzhyshkowska, Julia ^a   Géraud, Cyrill ^a   Goerdt, Sergij ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

MS4A family; p38 MAPK pathway; tumor immunity; tumor associated macrophages

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; JANUS KINASE; MEMBRANE PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN MS4A8A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CELL DIFFERENTIATION; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; GENE CONTROL; GENE EXPRESSION PROFILING; GROWTH INHIBITION; GROWTH RATE; IMMUNE RESPONSE; MELANOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD20; CELL LINE; CULTURE MEDIA, CONDITIONED; FEMALE; GLUCOCORTICOIDS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 79955408332     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25657     Document Type: Article

References (41)

1. Sica A, Allavena P, Mantovani A,. Cancer related inflammation: the macrophage connection. Cancer Lett 2008; 267: 204-15.
2. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S,. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 2005; 14: 425-31.
3. Canioni D, Salles G, Mounier N, Brousse N, Keuppens M, Morchhauser F, Lamy T, Sonet A, Rousselet MC, Foussard C, Xerri L,. High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. J Clin Oncol 2008; 26: 440-6. (Pubitemid 351171697)
4. Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD, Bast MA, Rosenwald A, et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 362: 875-85.
5. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A,. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549-55. (Pubitemid 35223554)
6. Goerdt S, Politz O, Schledzewski K, Birk R, Gratchev A, Guillot P, Hakiy N, Klemke CD, Dippel E, Kodelja V, Orfanos CE,. Alternative versus classical activation of macrophages. Pathobiology 1999; 67: 222-6. (Pubitemid 30135909)
7. Goerdt S, Orfanos CE,. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999; 10: 137-42. (Pubitemid 29115619)
8. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P, Mantovani A,. Macrophage polarization in tumour progression. Semin Cancer Biol 2008; 18: 349-55.
9. Stein M, Keshav S, Harris N, Gordon S,. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992; 176: 287-92.
10. Goerdt S, Bhardwaj R, Sorg C,. Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. Am J Pathol 1993; 142: 1409-22. (Pubitemid 24058128)
11. Kzhyshkowska J, Gratchev A, Schmuttermaier C, Brundiers H, Krusell L, Mamidi S, Zhang J, Workman G, Sage EH, Anderle C, Sedlmayr P, Goerdt S,. Alternatively activated macrophages regulate extracellular levels of the hormone placental lactogen via receptor-mediated uptake and transcytosis. J Immunol 2008; 180: 3028-37.
12. Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, Bottazzi B, Doni A, Vincenzo B, Pasqualini F, Vago L, Nebuloni M, et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood 2006; 107: 2112-22. (Pubitemid 43289397)
13. Hagemann T, Lawrence T, McNeish I, Charles KA, Kulbe H, Thompson RG, Robinson SC, Balkwill FR,. "Re-educating" tumor-associated macrophages by targeting NF-kappaB. J Exp Med 2008; 205: 1261-8. (Pubitemid 351831483)
14. Jassar AS, Suzuki E, Kapoor V, Sun J, Silverberg MB, Cheung L, Burdick MD, Strieter RM, Ching LM, Kaiser LR, Albelda SM,. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma. Cancer Res 2005; 65: 11752-61. (Pubitemid 41821737)
15. Ishibashi K, Suzuki M, Sasaki S, Imai M,. Identification of a new multigene four-transmembrane family (MS4A) related to CD20, HTm4 and beta subunit of the high-affinity IgE receptor. Gene 2001; 264: 87-93. (Pubitemid 32195491)
16. Kutok JL, Yang X, Folkerth R, Adra CN,. Characterization of the expression of HTm4 (MS4A3), a cell cycle regulator, in human peripheral blood cells and normal and malignant tissues. J Cell Mol Med, in press.
17. Berinstein NL, Grillo-Lopez AJ, White CA, Bence-Bruckler I, Maloney D, Czuczman M, Green D, Rosenberg J, McLaughlin P, Shen D,. Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol 1998; 9: 995-1001. (Pubitemid 28496709)
18. Schledzewski K, Falkowski M, Moldenhauer G, Metharom P, Kzhyshkowska J, Ganss R, Demory A, Falkowska-Hansen B, Kurzen H, Ugurel S, Geginat G, Arnold B, et al. Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J Pathol 2006; 209: 67-77.
19. Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, Tomita M, Van Rooijen N, Takenaka H, D'Amore PA, Stein-Streilein J, Losordo DW, Streilein JW,. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 2005; 115: 2363-72. (Pubitemid 41266198)
20. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, Schutz G,. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998; 93: 531-41. (Pubitemid 28240715)
21. Hsieh WP, Chu TM, Wolfinger RD, Gibson G,. Mixed-model reanalysis of primate data suggests tissue and species biases in oligonucleotide-based gene expression profiles. Genetics 2003; 165: 747-57. (Pubitemid 37337640)
22. Guiducci C, Di Carlo E, Parenza M, Hitt M, Giovarelli M, Musiani P, Colombo MP,. Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor. J Immunol 2004; 172: 4026-36. (Pubitemid 38375214)
23. Rehli M, Sulzbacher S, Pape S, Ravasi T, Wells CA, Heinz S, Sollner L, El Chartouni C, Krause SW, Steingrimsson E, Hume DA, Andreesen R,. Transcription factor Tfec contributes to the IL-4-inducible expression of a small group of genes in mouse macrophages including the granulocyte colony-stimulating factor receptor. J Immunol 2005; 174: 7111-22. (Pubitemid 40705677)
24. Moffatt MF,. SPINK5: a gene for atopic dermatitis and asthma. Clin Exp Allergy 2004; 34: 325-7. (Pubitemid 38372991)
25. Hiragun T, Peng Z, Beaven MA,. Cutting edge: dexamethasone negatively regulates Syk in mast cells by up-regulating SRC-like adaptor protein. J Immunol 2006; 177: 2047-50. (Pubitemid 44200960)
26. Biswas SK, Sica A, Lewis CE,. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol 2008; 180: 2011-17.
27. Adra CN, Lelias JM, Kobayashi H, Kaghad M, Morrison P, Rowley JD, Lim B,. Cloning of the cDNA for a hematopoietic cell-specific protein related to CD20 and the beta subunit of the high-affinity IgE receptor: evidence for a family of proteins with four membrane-spanning regions. Proc Natl Acad Sci USA 1994; 91: 10178-82.
28. Liang Y, Tedder TF,. Identification of a CD20-, FcepsilonRIbeta-, and HTm4-related gene family: sixteen new MS4A family members expressed in human and mouse. Genomics 2001; 72: 119-27. (Pubitemid 32242951)
29. Donato JL, Ko J, Kutok JL, Cheng T, Shirakawa T, Mao XQ, Beach D, Scadden DT, Sayegh MH, Adra CN,. Human HTm4 is a hematopoietic cell cycle regulator. J Clin Invest 2002; 109: 51-8. (Pubitemid 34052541)
30. Stashenko P, Nadler LM, Hardy R, Schlossman SF,. Characterization of a human B lymphocyte-specific antigen. J Immunol 1980; 125: 1678-85. (Pubitemid 10018582)
31. Koslowski M, Sahin U, Dhaene K, Huber C, Tureci O,. MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes. Cancer Res 2008; 68: 3458-66.
32. Kuijpers TW, Bende RJ, Baars PA, Grummels A, Derks IA, Dolman KM, Beaumont T, Tedder TF, van Noesel CJ, Eldering E, van Lier RA,. CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest 20: 214-22.
33. Chavanas S, Garner C, Bodemer C, Ali M, Teillac DH, Wilkinson J, Bonafe JL, Paradisi M, Kelsell DP, Ansai S, Mitsuhashi Y, Larregue M, et al. Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping. Am J Hum Genet 2000; 66: 914-21. (Pubitemid 30470493)
34. Spoelgen R, von Arnim CA, Thomas AV, Peltan ID, Koker M, Deng A, Irizarry MC, Andersen OM, Willnow TE, Hyman BT,. Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and beta-secretase beta-site APP-cleaving enzyme. J Neurosci 2006; 26: 418-28. (Pubitemid 43237105)
35. Botelho MG, Wang X, Arndt-Jovin DJ, Becker D, Jovin TM,. Induction of terminal differentiation in melanoma cells on downregulation of beta-amyloid precursor protein. J Invest Dermatol 130: 1400-10.
36. Sosinowski T, Pandey A, Dixit VM, Weiss A,. Src-like adaptor protein (SLAP) is a negative regulator of T cell receptor signaling. J Exp Med 2000; 191: 463-74.
37. Szollosi J, Horejsi V, Bene L, Angelisova P, Damjanovich S,. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J Immunol 1996; 157: 2939-46. (Pubitemid 126450050)
38. Howie D, Nolan KF, Daley S, Butterfield E, Adams E, Garcia-Rueda H, Thompson C, Saunders NJ, Cobbold SP, Tone Y, Tone M, Waldmann H,. MS4A4B is a GITR-associated membrane adapter, expressed by regulatory T cells, which modulates T cell activation. J Immunol 2009; 183: 4197-204.
39. Kumar S, Boehm J, Lee JC,. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003; 2: 717-26. (Pubitemid 37361787)
40. Goebeler M, Gillitzer R, Kilian K, Utzel K, Brocker EB, Rapp UR, Ludwig S,. Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells. Blood 2001; 97: 46-55. (Pubitemid 32061241)
41. Miller AL, Webb MS, Copik AJ, Wang Y, Johnson BH, Kumar R, Thompson EB,. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 2005; 19: 1569-83. (Pubitemid 41002986)